Investigation of the effects of mesenchymal stem cell administration on liver recovery in experimental hepatotoxicity model

Basit Öğe Kaydı
dc.contributor.authorBoztok Özgermen, Başak
dc.contributor.authorYavuz, Orhan
dc.contributor.authorHaydardedeoğlu, Ali Evren
dc.date.accessioned2025-09-11T06:08:43Z
dc.date.available2025-09-11T06:08:43Z
dc.date.issued2022
dc.departmentVeteriner Fakültesi
dc.description.abstractHepatotoxicity refers to liver dysfunction associated with certain medical drugs and chemicals. Studies have shown that mesenchymal stem cells have a positive effect on the improvement of liver diseases. This study aimed to investigate the potential protective effects of fetal kidney-induced mesenchymal stem cells on Doxorubicin- induced hepatotoxicity in rats. Sprague dawley rats were divided into three groups: Control, sham, and treatment group. Intraperitoneally administered mesenchymal stem cells were treated with BrdU before transplantation so that they could be followed up after invivo transplantation. After completion of the experimental steps, the groups were monitored for 5 weeks. Then the rats were terminated and liver tissues were taken for histopathological and immunohistochemical evaluation. In immunohistochemical examinations performed with TNF-α, Caspase-3, and COX-2 primary antibodies, the most severe positivity was in the sham group, followed by the control and treatment groups. While the control and sham groups were found to be statistically similar in immunohistochemical staining with anti-BrdU antibody, the treatment group was found to be significantly different from the other groups (p<0.05). As a result, it has been revealed that intraperitoneally administered mesenchymal stem cells prevent degeneration and necrosis in hepatocytes, significantly decreasing TNF-α, COX-2, and Caspase-3 levels thus increasing liver regeneration in rats with Doxorubicin-induced hepatotoxicity.
dc.identifier.doi10.31797/vetbio.1029373
dc.identifier.endpage193
dc.identifier.issn2548-1150
dc.identifier.issue2
dc.identifier.startpage185
dc.identifier.urihttps://doi.org/10.31797/vetbio.1029373
dc.identifier.urihttps://hdl.handle.net/20.500.12451/14294
dc.identifier.volume7
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorBoztok Özgermen, Başak
dc.institutionauthorYavuz, Orhan
dc.institutionauthorHaydardedeoğlu, Ali Evren
dc.institutionauthorid0000-0001-7039-8956
dc.institutionauthorid0000-0002-8075-9564
dc.institutionauthorid0000-0002-8473-0072
dc.language.isoen
dc.publisherİlker ÇAMKERTEN
dc.relation.ispartofJournal of Advances in VetBio Science and Techniques
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDoxorubicin
dc.subjectHepatotoxicity
dc.subjectMesenchymal Stem Cell
dc.subjectRat
dc.titleInvestigation of the effects of mesenchymal stem cell administration on liver recovery in experimental hepatotoxicity model
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
boztok ozgermen-basak-2022.pdf
Boyut:
648.32 KB
Biçim:
Adobe Portable Document Format
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Makale Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu